Parnassus Investments, an investment management firm, released its “Parnassus Value Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund focuses on ...
Stryker Corporation (NYSE:SYK) is included among the 15 Blue Chip Dividend Stocks to Build a Passive Income Porfolio. On November 14, Truist’s analyst Richard Newitter boosted the price target on ...
If you are wondering whether Stryker at around $351 a share is still a smart buy, or if the best days are already priced in, ...
Even with impact of currency exchange rates, Stryker was able to have organic growth of 6.4%. The Dividend Contender has raised dividends 23 straight years. The five-year average dividend growth rate ...
Stryker has performed well year-to-date, with an 18% increase in stock price, outperforming the S&P 500 ETF Trust. The company has shown strong revenue growth, with a minor drop in 2020 due to ...
If you want to know who really controls Stryker Corporation (NYSE:SYK), then you'll have to look at the makeup of its share registry. We can see that institutions own the lion's share in the company ...
Medical technology company Stryker last week announced the expansion of its Salt Lake City operations in a move the company ...
Stryker (NYSE: SYK) is a medical device company that has risen to become the third-largest U.S. firm in the healthcare equipment and supplies industry. The company has often acquired other firms to ...
The medtech company Stryker has received incentives from the state for its Salt Lake City operations, and plans to add more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results